These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8299434)

  • 41. Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.
    Akturk HK; Snell-Bergeon JK; Rewers A; Klaff LJ; Bode BW; Peters AL; Bailey TS; Garg SK
    Diabetes Technol Ther; 2018 Oct; 20(10):639-647. PubMed ID: 30207748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Follow-up of the Berlin Retinopathy Study.
    Danne T; Weber B; Hartmann R; Enders I; Burger W; Hovener G
    Diabetes Care; 1994 Dec; 17(12):1390-6. PubMed ID: 7882807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
    Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
    Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of 24-hour glycemic excursions in patients with type 1 diabetes by using continuous glucose monitoring.
    Taki K; Nishimura R; Morimoto A; Tsujino D; Miyashita Y; Tajima N
    Diabetes Technol Ther; 2010 Jul; 12(7):523-8. PubMed ID: 20597826
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes.
    Kinsley BT; Weinger K; Bajaj M; Levy CJ; Simonson DC; Quigley M; Cox DJ; Jacobson AM
    Diabetes Care; 1999 Jul; 22(7):1022-8. PubMed ID: 10388961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequency and Predictors of Self-Reported Hypoglycemia in Insulin-Treated Diabetes.
    Malkani S; Kotwal A
    J Diabetes Res; 2017; 2017():7425925. PubMed ID: 28913365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus.
    Alemzadeh R; Loppnow C; Parton E; Kirby M
    Diabetes Technol Ther; 2003; 5(2):167-73. PubMed ID: 12871606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Continuous Glucose Monitoring in People With Type 1 Diabetes on Multiple-Dose Injection Therapy: The Relationship Between Glycemic Control and Hypoglycemia.
    Oliver N; Gimenez M; Calhoun P; Cohen N; Moscardo V; Hermanns N; Freckmann G; Reddy M; Heinemann L
    Diabetes Care; 2020 Jan; 43(1):53-58. PubMed ID: 31530662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Revisiting the Relationships Between Measures of Glycemic Control and Hypoglycemia in Continuous Glucose Monitoring Data Sets.
    Gimenez M; Tannen AJ; Reddy M; Moscardo V; Conget I; Oliver N
    Diabetes Care; 2018 Feb; 41(2):326-332. PubMed ID: 29191845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes.
    Bulsara MK; Holman CD; Davis EA; Jones TW
    Diabetes Care; 2004 Oct; 27(10):2293-8. PubMed ID: 15451890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Aiello LP;
    Diabetes Care; 2014; 37(1):17-23. PubMed ID: 24356593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No deleterious effects of tight blood glucose control on 24-hour ambulatory blood pressure in normoalbuminuric insulin-dependent diabetes mellitus patients.
    Poulsen PL; Hansen KW; Ebbehøj E; Knudsen ST; Mogensen CE
    J Clin Endocrinol Metab; 2000 Jan; 85(1):155-8. PubMed ID: 10634379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dietary pectin and glycemic control in diabetes.
    Gardner DF; Schwartz L; Krista M; Merimee TJ
    Diabetes Care; 1984; 7(2):143-6. PubMed ID: 6376010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relationship of glycemic control, insulin dose, and race with hypoglycemia in youth with type 1 diabetes.
    Chalew S; Kamps J; Jurgen B; Gomez R; Hempe J
    J Diabetes Complications; 2020 Jun; 34(6):107519. PubMed ID: 32303406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glycemic Variability Is Associated with Frequency of Blood Glucose Testing and Bolus: Post Hoc Analysis Results from the ProAct Study.
    Pfützner A; Weissmann J; Mougiakakou S; Daskalaki E; Weis N; Ziegler R
    Diabetes Technol Ther; 2015 Jun; 17(6):392-7. PubMed ID: 25734860
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypoglycemia as a barrier to glycemic control.
    Davis S; Alonso MD
    J Diabetes Complications; 2004; 18(1):60-8. PubMed ID: 15019602
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma catecholamine responses to hypoglycemia in children and adolescents with IDDM.
    Hoffman RP; Singer-Granick C; Drash AL; Becker DJ
    Diabetes Care; 1991 Feb; 14(2):81-8. PubMed ID: 2060427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
    Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
    Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [What glycemic control can be achieved in young diabetics without residual secretion of endogenous insulin? What is the frequency of severe hypoglycemia and subclinical complications?].
    Dorchy H
    Arch Pediatr; 1994 Nov; 1(11):970-81. PubMed ID: 7834046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The phenomenon of HbA1c stability and the risk of hypoglycemia in long-standing type 1 diabetes.
    Wolnik B; Orłowska-Kunikowska E; Błaszkowska M; Graff B; Wolf J; Czupryniak L; Narkiewicz K
    Diabetes Res Clin Pract; 2019 Jun; 152():96-102. PubMed ID: 31108139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.